# Southern First Bancshares Inc: financial statements, quarterly

SFST · Nasdaq · CIK 1090009 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/sfst.md) · [Financials](/companies/sfst/financials.md) · [Filings](/companies/sfst/filings.md) · [Insiders](/companies/sfst/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/sfst/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [1.2](/filings/0001206774-24-000990.md) | [0.9 d](/filings/0001206774-26-000084.md) | [1.2](/filings/0001206774-25-000343.md) | [1.9](/filings/0001206774-25-000538.md) | [1.4](/filings/0001206774-25-000738.md) | [1.0 d](/filings/0001206774-26-000084.md) | [1.4](/filings/0001206774-26-000259.md) | [1.6](/filings/0001206774-26-000404.md) | [1.6](/filings/0001206774-25-000738.md) | [1.7 d](/filings/0001206774-26-000084.md) | [1.5](/filings/0001206774-26-000259.md) | [1.3](/filings/0001206774-26-000404.md) |
| Interest expense | $m | [28.1](/filings/0001206774-23-001219.md) | [30.1 d](/filings/0001206774-24-000233.md) | [29.7](/filings/0001206774-24-000471.md) | [31.0](/filings/0001206774-24-000719.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [1.2](/filings/0001206774-24-000990.md) | [1.2 d](/filings/0001206774-26-000084.md) | [0.9](/filings/0001206774-25-000343.md) | [0.9](/filings/0001206774-25-000538.md) | [1.3](/filings/0001206774-25-000738.md) | [1.3 d](/filings/0001206774-26-000084.md) | [1.6](/filings/0001206774-26-000259.md) | [2.0](/filings/0001206774-26-000404.md) | [2.7](/filings/0001206774-25-000738.md) | [2.9 d](/filings/0001206774-26-000084.md) | [2.6](/filings/0001206774-26-000259.md) | [3.3](/filings/0001206774-26-000404.md) |
| Net income | $m | [4.1](/filings/0001206774-24-000990.md) | [4.2 d](/filings/0001206774-26-000084.md) | [2.5](/filings/0001206774-25-000343.md) | [3.0](/filings/0001206774-25-000538.md) | [4.4](/filings/0001206774-25-000738.md) | [5.6 d](/filings/0001206774-26-000084.md) | [5.3](/filings/0001206774-26-000259.md) | [6.6](/filings/0001206774-26-000404.md) | [8.7](/filings/0001206774-25-000738.md) | [9.9 d](/filings/0001206774-26-000084.md) | [9.9](/filings/0001206774-26-000259.md) | [11.2](/filings/0001206774-26-000404.md) |
| Diluted EPS | $ per share | [0.51](/filings/0001206774-24-000990.md) | not reported | [0.31](/filings/0001206774-25-000343.md) | [0.37](/filings/0001206774-25-000538.md) | [0.54](/filings/0001206774-25-000738.md) | not reported | [0.65](/filings/0001206774-26-000259.md) | [0.81](/filings/0001206774-26-000404.md) | [1.07](/filings/0001206774-25-000738.md) | not reported | [1.19](/filings/0001206774-26-000259.md) | [1.20](/filings/0001206774-26-000404.md) |
| Basic EPS | $ per share | [0.51](/filings/0001206774-24-000990.md) | not reported | [0.31](/filings/0001206774-25-000343.md) | [0.37](/filings/0001206774-25-000538.md) | [0.54](/filings/0001206774-25-000738.md) | not reported | [0.65](/filings/0001206774-26-000259.md) | [0.81](/filings/0001206774-26-000404.md) | [1.08](/filings/0001206774-25-000738.md) | not reported | [1.21](/filings/0001206774-26-000259.md) | [1.22](/filings/0001206774-26-000404.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Total assets | $m | [4,020](/filings/0001206774-23-001219.md) | [4,056](/filings/0001206774-25-000099.md) | [4,106](/filings/0001206774-24-000471.md) | [4,110](/filings/0001206774-24-000719.md) | [4,175](/filings/0001206774-24-000990.md) | [4,088](/filings/0001206774-26-000084.md) | [4,284](/filings/0001206774-25-000343.md) | [4,308](/filings/0001206774-25-000538.md) | [4,359](/filings/0001206774-25-000738.md) | [4,403](/filings/0001206774-26-000404.md) | [4,578](/filings/0001206774-26-000259.md) | [4,700](/filings/0001206774-26-000404.md) |
| Total liabilities | $m | [3,716](/filings/0001206774-23-001219.md) | [3,743](/filings/0001206774-25-000099.md) | [3,790](/filings/0001206774-24-000471.md) | [3,791](/filings/0001206774-24-000719.md) | [3,848](/filings/0001206774-24-000990.md) | [3,757](/filings/0001206774-26-000084.md) | [3,947](/filings/0001206774-25-000343.md) | [3,963](/filings/0001206774-25-000538.md) | [4,002](/filings/0001206774-25-000738.md) | [4,035](/filings/0001206774-26-000404.md) | [4,199](/filings/0001206774-26-000259.md) | [4,248](/filings/0001206774-26-000404.md) |
| Shareholders' equity | $m | [304](/filings/0001206774-24-000990.md) | [312](/filings/0001206774-26-000084.md) | [315](/filings/0001206774-25-000538.md) | [319](/filings/0001206774-25-000738.md) | [327](/filings/0001206774-25-000738.md) | [330](/filings/0001206774-26-000404.md) | [338](/filings/0001206774-26-000404.md) | [345](/filings/0001206774-26-000404.md) | [356](/filings/0001206774-25-000738.md) | [369](/filings/0001206774-26-000404.md) | [379](/filings/0001206774-26-000404.md) | [452](/filings/0001206774-26-000404.md) |

- Cash and equivalents: not reported
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [16.1 d](/filings/0001206774-24-000990.md) | [6.9 d](/filings/0001206774-26-000084.md) | [(2.9)](/filings/0001206774-25-000343.md) | [4.0 d](/filings/0001206774-25-000538.md) | [26.3 d](/filings/0001206774-25-000738.md) | [(1.8) d](/filings/0001206774-26-000084.md) | [7.6](/filings/0001206774-26-000259.md) | [10.5 d](/filings/0001206774-26-000404.md) | [14.5 d](/filings/0001206774-25-000738.md) | [(2.1) d](/filings/0001206774-26-000084.md) | [10.8](/filings/0001206774-26-000259.md) | [18.0 d](/filings/0001206774-26-000404.md) |
| Capital expenditure | $m | [0.4 d](/filings/0001206774-24-000990.md) | [0.1 d](/filings/0001206774-26-000084.md) | [0.3](/filings/0001206774-25-000343.md) | [0.1 d](/filings/0001206774-25-000538.md) | [0.2 d](/filings/0001206774-25-000738.md) | [0.2 d](/filings/0001206774-26-000084.md) | [0.1](/filings/0001206774-26-000259.md) | [0.1 d](/filings/0001206774-26-000404.md) | [0.1 d](/filings/0001206774-25-000738.md) | [0.3 d](/filings/0001206774-26-000084.md) | [0.3](/filings/0001206774-26-000259.md) | [1.3 d](/filings/0001206774-26-000404.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | thousands of shares | [8,065](/filings/0001206774-23-001219.md) | [8,092](/filings/0001206774-24-000471.md) | [8,069](/filings/0001206774-24-000719.md) | [8,072](/filings/0001206774-24-000990.md) | [8,142](/filings/0001206774-25-000343.md) | [8,141](/filings/0001206774-25-000538.md) | [8,089](/filings/0001206774-25-000738.md) | [8,111](/filings/0001206774-26-000259.md) | [8,134](/filings/0001206774-26-000404.md) | [8,080](/filings/0001206774-25-000738.md) | [8,293](/filings/0001206774-26-000259.md) | [9,319](/filings/0001206774-26-000404.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 9,471,755 at 2026-07-28, from the cover of the [10-Q filed 2026-08-03](/filings/0001206774-26-000404.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:33 ET. No prices; not investment advice.